The hypoxia marker CAIX is prognostic in the UK phase III VorteX-Biobank cohort: an important resource for translational research in soft tissue sarcoma

BACKGROUND: Despite high metastasis rates, adjuvant/neoadjuvant systemic therapy for localised soft tissue sarcoma (STS) is not used routinely. Progress requires tailoring therapy to features of tumour biology, which need exploration in well-documented cohorts. Hypoxia has been linked to metastasis...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Forker, Laura, Gaunt, Piers, Sioletic, Stefano, Shenjere, Patrick, Potter, Robert, Roberts, Darren, Irlam, Joely, Valentine, Helen, Hughes, David, Hughes, Ana, Billingham, Lucinda, Grimer, Rob, Seddon, Beatrice, Choudhury, Ananya, Robinson, Martin, West, Catharine M L
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2018
Assuntos:
Molecular Diagnostics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5846059/
https://ncbi.nlm.nih.gov/pubmed/29235571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2017.430
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados